Merck & Co., Inc. is 106.5x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($294.13 B vs $2.76 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLNO | MRK |
|---|---|---|
| Market cap | $2.76 B | $294.13 B |
| US-listed rank | #1873 | #44 |
| Revenue (latest FY) | $190.41M | $65.01B |
| Net income (latest FY) | $20.89M | $18.25B |
| Net margin | 11.0% | 28.1% |
| P/E (trailing FY) | 132.3 | 16.1 |
| SEC filings | 1,119 | 996 |
Merck & Co., Inc. is 106.5x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($294.13 B vs $2.76 B).
In their latest fiscal years, SOLENO THERAPEUTICS INC reported $190.41M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: SOLENO THERAPEUTICS INC and Merck & Co., Inc., or browse the full rankings.